Attitudes, beliefs toward end-of-life care differ between hematologic, solid tumor specialists
the ONA take:
Researchers at the University of Texas MD Anderson Cancer Center conducted a survey to compare the attitudes and beliefs toward palliative care among hematologic versus solid tumor specialists.
They randomly surveyed 120 hematologists and 120 solid tumor oncologists at the institution; 182 clinicians (76%) responded.
The survey questions examined the participants’ attitudes toward various aspects of end-of-life care, including use of palliative systemic therapy.
The researchers found significant differences in attitudes and beliefs toward end-of-life care. Hematologic specialty and comfort level with prescribing treatment to patients with Eastern Cooperative Oncology Group performance status 4 and an expected survival of 1 month were associated with the decision to treat in the last month of life.
Survey compares attitudes and beliefs toward palliative care among hematologic versus solid tumor specialists.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Affect of Daratumumab on Laboratory Blood Test Results
- Geriatric Consults Rare in Kidney Cancer Care
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|